Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: A retrospective cohort study

BMC Palliative Care

Volumn 14, Issue 1, 2015, Pages

  Kondoh, Chihiro ^a,b   Shitara, Kohei ^a,c   Nomura, Motoo ^a   Takahari, Daisuke ^a   Ura, Takashi ^a   Tachibana, Hiroyuki ^a   Tomita, Natsuo ^a   Kodaira, Takeshi ^a   Muro, Kei ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Bleeding; Gastric cancer; Hemostasis; Palliative care; Radiotherapy

Indexed keywords

CISPLATIN; CREATININE; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; LAPATINIB; METHOTREXATE; OXALIPLATIN; PACLITAXEL; PROTON PUMP INHIBITOR; THROMBIN; TRANEXAMIC ACID; TRASTUZUMAB;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIARRHEA; DRUG SAFETY; FATIGUE; FEMALE; HEALTH CARE UTILIZATION; HEMATEMESIS; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; INOPERABLE CANCER; LIFE EXPECTANCY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MELENA; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PALLIATIVE THERAPY; PLEURA EFFUSION; RADIATION DOSE; RETROSPECTIVE STUDY; SIDE EFFECT; STOMACH CANCER; STOMACH HEMORRHAGE; THROMBOCYTOPENIA; VERY ELDERLY; VOMITING; COMPLICATION; GASTROINTESTINAL HEMORRHAGE; MIDDLE AGED; PROCEDURES; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 84938592496     PISSN: None     EISSN: 1472684X     Source Type: Journal    
DOI: 10.1186/s12904-015-0034-y     Document Type: Article

References (30)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Mathers C, Robelo M, Parkin DM, Forman D, Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed 30 November 2014.
2. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725-30.
3. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;358:1810-20.
4. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315-21.
5. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. MAGIC trial participants: perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
6. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074-84.
7. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Clinical Transfusion Medicine Committee of the AABB: Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB∗. Ann Intern Med. 2012;157:49-58.
8. No author listed. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party. Br J Cancer. 1992;65:934-41
9. Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2000;47:149-55.
10. van Lonkhuijzen L, Thomas G. Palliative radiotherapy for cervical carcinoma, a systematic review. Radiother Oncol. 2011;98:287-91.
11. Duchesne GM, Bolger JJ, Griffiths GO, Trevor Roberts J, Graham JD, Hoskin PJ, et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. Int J Radiat Oncol Biol Phys. 2000;47:379-88.
12. Tey J, Back MF, Shakespeare TP, Mukherjee RK, Lu JJ, Lee KM, et al. The role of palliative radiation therapy in symptomatic locally advanced gastric cancer. Int J Radiat Oncol Biol Phys. 2007;67:385-8.
13. Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, et al. Clinical benefit of palliative radiation therapy in advanced gastric cancer. Acta Oncol. 2008;47:421-7.
14. Hashimoto K, Mayahara H, Takashima A, Nakajima TE, Kato K, Hamaguchi T, et al. Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience. J Cancer Res Clin Oncol. 2009;135:1117-23.
15. Asakura H, Hashimoto T, Harada H, Mizumoto M, Furutani K, Hasuike N, et al. Palliative radiotherapy for bleeding from advanced gastric cancer: is a schedule of 30 Gy in 10 fractions adequate? J Cancer Res Clin Oncol. 2011;137:125-30.
16. Lee JA, Lim do H, Park W, Ahn YC, Huh SJ. Radiation therapy for gastric cancer bleeding. Tumori. 2009;95:726-30.
17. Tey J, Choo BA, Leong CN, Loy EY, Wong LC, Lim K, et al. Clinical outcome of palliative radiotherapy for locally advanced symptomatic gastric cancer in the modern era. Medicine (Baltimore). 2014;93:e118.
18. Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014;383:31-9.
19. Ohtsu A, Ajani JA, Bai YX, Bang YJ, Chung HC, Pan HM, et al. Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study. J Clin Oncol. 2013;31:3935-43.
20. Kang JH, Lee SI, Lim do H, Park KW, Oh SY, Kwon HC, et al. Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. J Clin Oncol. 2012;30:1513-8.
21. Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996;32A:1135-41.
22. Morita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7:128-33.
23. Buergy D, Lohr F, Baack T, Siebenlist K, Haneder S, Michaely H, et al. Radiotherapy for tumors of the stomach and gastroesophageal junction - a review of its role in multimodal therapy. Radiat Oncol. 2012;7:192.
24. Henning GT, Schild SE, Stafford SL, Donohue JH, Burch PA, Haddock MG, et al. Results of irradiation or chemoirradiation for primary unresectable, locally recurrent, or grossly incomplete resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys. 2000;46:109-18.
25. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med. 1999;340:1555-64.
26. Borissoff JI, Spronk HMH, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364:1746-60.
27. Jourdan A, Aguejouf O, Imbault P, Doutremepuich F, Inamo J, Doutremepuich C. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances. Thromb Res. 1995;79:109-23.
28. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927-9.
29. Goldin-Lang P, Niebergall F, Antoniak S, Szotowski B, Rosenthal P, Pels K, et al. Ionizing radiation induces upregulation of cellular procoagulability and tissue factor expression in human peripheral blood mononuclear cells. Thromb Res. 2007;120:857-64.
30. Onsrud M, Hagen B, Strickert T. 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri. Gynecol Oncol. 2001;82:167-71.